Five-year results from the AVALON registry on percutaneous versus surgical treatment of aortic stenosis in low-risk patients, compared to updated evidence from key clinical trials for the same patient profile.
An expert commentary by Dra. Sonia Mirabet about choices for advanced heart failure therapies.
A systematic review analyzing nearly 1000 pediatric Berlin Heart® implants to describe the characteristics of patients who achieved successful explantation.
Validation of the perioperative risk prediction system for patients undergoing type A aortic dissection repair derived from the GERAADA German registry.
A retrospective analysis was conducted to evaluate the evolution and outcomes of cardiac surgery in patients with prior TAVI, utilizing data from the STS database from 2012 to 2023.
This literature review revisits the pathophysiological principles of ischemia, reperfusion, and myocardial ischemia tolerance, as well as the concepts of myocardial protectioN and the main evidence on outcomes among different cardioplegia solutions retrospectively since 2020.
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Dr. Encarnación Gutiérrez’s review discusses the current state of managing infections associated with cardiac stimulation devices (CSDs), addressing the increase in associated costs due to three primary factors.
A retrospective study conducted by Yale University over three decades scrutinizes the data from its Aortic Institute to assess the validity of surgical indications for rapid growth exceeding 3 mm/year.
A retrospective study conducted in the United States analyzed the incidence, outcomes, and costs associated with heparin-induced thrombocytopenia (HIT) in patients undergoing cardiac surgery.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.